Alvarez & Marsal Announces 2025 Managing Director Promotions
16.1.2025 17:36:00 CET | Business Wire | Press release
Leading global professional services firm Alvarez & Marsal (A&M) has announced the promotion of 80 professionals, across Brazil, Canada, France, Germany, India, Italy, Spain, Sweden, United Arab Emirates, United Kingdom, and the United States, to the position of Managing Director.
Tony Alvarez II and Bryan Marsal, A&M’s Co-Founders, stated, “All of our newly promoted Managing Directors embody the talent and leadership necessary to deliver exceptional results that create value for A&M’s clients. Their contributions to the growth of our firm and the clients we serve cannot be understated. From around the world and across our many lines of service, they exemplify A&M’s unwavering commitment to integrity, quality and objectivity, and are essential to the firm’s continued success and expansion.”
- Russell Hunt, Houston
- Jack Kobus, Detroit
- Long Nguyen, Washington, D.C.
- Luis De Lencquesaing, New York
- Christopher Disa, New York
- Phani Mogalapu,Houston
Corporate Performance Improvement
- Kindra Bradshaw, Washington, D.C.
- Clark Caperton, Houston
- Rodrigo Carrillo, Houston
- Jeffrey Cass, Houston
- Trey Huffman, Atlanta
- Rob Koczo,Dallas
- Haley Leyendecker, Denver
- Andrew Monaco, Dallas
- Dan Phillips, Atlanta
- Brenden Phillips-Garrett, Los Angeles
- Eduardo Areilza, Madrid
- Massimo Franzese, London
- Tom Howitt, Abu Dhabi
- Hardeep Sandhu, London
- Florian Seehauser, Munich
- Jonas Strasdas, Munich
Private Equity Performance Improvement
- Colleen McCaughan, London
- Nick Mountfield, London
- Daniela Torresin, Milan
- Dario Bortot,London
- John Costoudes, Dubai
- Elizaveta Malashenko, Houston
Global Disputes and Investigations
- Jon Ahern, Denver
- Brad Koehler, New York
- John Bettley-Smith, London
- Daniella Divito,New York
- Emily Edwards, Atlanta
- Orion Ganase,London
- Alon Kritzman, New York
- Bruce Meyer, San Francisco
- Michael Noreman, Morristown
- Axel Ortjohann, Frankfurt
- Rob Piechota, Atlanta
- Chris Prout, London
Global Transaction Advisory Group
- Mike Baxter,Toronto
- Erminio Caporale, Chicago
- Kevin Cunha,San Francisco
- Ryan Donovan,Boston
- Vivian Leemans,Düsseldorf
- Kate Lowry,New York
- Ryan Macke, Chicago
- Callum Moore, Stockholm
- Gaurav Patel,Toronto
- Alex Rankin, Dubai
- Simon Regad,Paris
- Paul Spencer, London
- Michael Surr,New York
- Austin Wanland, Los Angeles
- Sujith Jain, Bangalore
Infrastructure & Capital Projects
- Felipe Bergson, Rio de Janeiro
- Bryan Müller, Belo Horizonte
- Alexandre Aguieiras, Rio de Janeiro
- Janice Garay, São Paulo
- Guilherme Kam, São Paulo
- Patrick Lopes, São Paulo
- Eduardo Teixeira, São Paulo
North American Commercial Restructuring
- Dwight Hingtgen,Chicago
- Landon Kenworthy,Dallas
- Paul Kinealy,Chicago
- Kumanan Ramanathan, New York
- Mauricio Rivera,San Francisco
- John Walsh,Houston
Private Equity Performance Improvement
- Alexander Galitsky,Chicago
- Vincent Juron,Charlotte
- Jason Kahn,Philadelphia
- Jeff Liddle, Houston
- Ahmed Suria,Philadelphia
- Ben Taylor,Atlanta
- Shiwali Tenner,Chicago
- Hameer Vaid,New York
- Christopher Baglio, Chicago
- Tracey Esposito, New York
- Roger Wilcock, London
About Alvarez & Marsal
Founded in 1983, Alvarez & Marsal is a leading global professional services firm. Renowned for its leadership, action and results, Alvarez & Marsal provides advisory, business performance improvement and turnaround management services, delivering practical solutions to address clients' unique challenges. With a world-wide network of experienced operators, world-class consultants, former regulators and industry authorities, Alvarez & Marsal helps corporates, boards, private equity firms, law firms and government agencies drive transformation, mitigate risk and unlock value at every stage of growth.
To learn more, visit: AlvarezandMarsal.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250114027719/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kiabi Selects Navan to Centralise Global Travel Program11.5.2026 09:00:00 CEST | Press release
Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Kiabi, the French multinational fashion retailer, to consolidate its global travel with one unified platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511547434/en/ Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform To support its workforce of nearly 10,000 “Kiabers,” the retailer required a solution capable of providing an easy-to-use travel platform. Navan was selected due to its intuitive AI-powered interface and ability to integrate with Kiabi’s travel policies directly in-app. “Managing travel was becoming an administrative burden that slowed our teams down,” said Denise Maurice, Indirect Procurement Director at Kiabi. “We wanted to give our ‘Kiabers’ the
Owl Labs partners with Westcoast to expand access to seamless hybrid meeting experiences in the UK and Ireland11.5.2026 09:00:00 CEST | Press release
Partnership aims to reduce the ‘meeting tax’ by expanding access to Owl Labs products through Westcoast’s extensive distribution network Owl Labs, a global leader in AI-powered, 360-degree video conferencing solutions, today announced a new UK and Ireland distribution partnership with Westcoast Limited, one of the country’s largest and most trusted IT distributors. The agreement will see Westcoast distribute the full range of Owl Labs’ award-winning Meeting Owl and Owl Bar products across the UK and Ireland, providing greater choice, availability, and dedicated support for resellers and end customers navigating the demands of hybrid work. The partnership aims to address the technical setup challenges that plague meetings across the UK. Owl Labs’ recent State of Hybrid Work report found that nearly 8 in 10 workers (79%) lose time in meetings due to technical difficulties such as connecting to a meeting or setting up a camera. By making Owl Labs’ solutions simpler to source, deploy and s
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay11.5.2026 09:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA). “With Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma now CE‑marked on our LUMIPULSE G platform, we are advancing a new era of neurology diagnostics—one where blood‑based biomarkers enable earlier, broader, and more accessible insights into Alzheimer’s disease and neurodegeneration.” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “By delivering fully automated and scalable solutions, we are helping clinicians move decisively toward more timely and informed decision‑making. This milestone underscores our long‑term vision to reimagine the diagnostic
Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 202611.5.2026 08:00:00 CEST | Press release
The MEVION S250-FIT™ creates a new pathway for European cancer centers to integrate proton therapy into existing radiotherapy programs Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507172087/en/ The MEVION S250-FIT™ Proton Therapy System Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, aligning advanced proton capability with the infrastructure, workflows, and capital planning of modern radiation oncology. Stanford Medicine: First S250-FIT Installation On April 7, 2026, Stanford Medicine unveiled
Vedanta FY26 Profit Soars by 22% to $2.8 bn; Enters Demerger Phase11.5.2026 02:30:00 CEST | Press release
India-based Vedanta Limited (BSE: 500295 & NSE: VEDL), a global leader in metals, oil & gas, critical minerals, power and technology, announced its results for the fourth quarter and full year ended 31 March 2026. It has delivered its best-ever financial performance, driven by structurally strong businesses and disciplined execution. For the full year, Vedanta’s Profit stood at an all-time high of $2.8 bn, reflecting a 22% YoY increase and a profit of $1 bn in Q4 FY26, up nearly 90% YoY. Vedanta reported its highest-ever annual revenue of about $20 bn, up 15% YoY, with Q4 revenue at $5.6 bn, an increase of nearly 30% YoY. The Company maintained strong cost leadership, contributing to record EBITDA of $6.3 bn for FY26, up by about 30% YoY, with margins expanding to around 40%. Q4 EBITDA stood at $2.0 bn, up by nearly 60% YoY, with a margin of approximately 44%. The balance sheet strengthened further, with Net Debt/EBITDA improving to 0.95x, supported by strong cash generation. Underscor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom